---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-009967"
form_type: "8-K"
ticker: "CCCC"
cik: "0001662579"
company_name: "C4 Therapeutics, Inc."
filed_at: "2024-03-08T23:59:59+00:00"
generated_at: "2026-06-05T00:34:34.746018+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# C4 Therapeutics reprices underwater employee options; new exercise prices $19.00 and $11.88

## Summary
- Eligible options with exercise price >$22.00 repriced to $19.00 for senior leadership and $11.88 for other employees.
- Repricing applies to CFO, CBO, CSO, CPO, and CLO; CEO and non-employee directors excluded.
- Repriced options revert to original exercise price if holder is terminated for cause or resigns before March 7, 2025.
- Board and Committee designed repricing as retention incentive without additional equity grants or cash compensation.
- Original exercise price threshold of $22.00 is over 2x the closing price and about 2.5x the 30-day VWAP on effective date.

## SEC filing metadata
- accession: 0001628280-24-009967
- form_type: 8-K
- ticker: CCCC
- cik: 0001662579
- company_name: C4 Therapeutics, Inc.
- filed_at: 2024-03-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1662579/000162828024009967/0001628280-24-009967-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1662579/000162828024009967/cccc-20240308.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-009967
- JSON: https://secwatch.observer/filing/0001628280-24-009967.json
- Plain text: https://secwatch.observer/filing/0001628280-24-009967.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.